Exploring Advances in Myopia Management
Myopia has become a major public health crisis with a rapidly increasing prevalence. Recent projections indicate that over 50% of the world’s population will have myopia by the year 2050. Drs. Murtaza Adam, Salil Shukla, and Rachel Lewis explore the science behind myopia management and best practices for slowing progression and implementing optical treatment.
Degenerative myopia affects up to 3% of the world’s population and can lead to progressive, irreversible vision loss. The prevalence of high myopia is increasing across the globe, projected to affect as many as 1 billion people by 2050. High myopia is a combination of refractive error and axial length, and can lead to complications such as chorioretinal atrophy, posterior staphyloma, foveoschisis, lacquer cracks, choroidal neovascularization, retinal tears and detachments. Both genetic and environmental factors are hypothesized to be at play in the development of degenerative myopia, requiring optometrists and ophthalmologists to work closely together for prevention and treatment. Join us for an overview of novel technologies in myopia prevention and the retinal approaches in treating pathologic myopia.
